Table 2 Haematological analyses in the five cats infected with Cytauxzoon sp. Results outside the reference interval are shown in bold font. Cases 1–3 were treated with azithromycin and atovaquone from day 1 to 10 and from day 77 to 86. Case 4 was treated with azithromycin from day 6 to 21 and from day 260 to 270 and with atovaquone from day 11 to 21
Parameter | Case | Day 0 (presentation) | Week 1 (days 1–7) | Week 2 (days 8–14) | Weeks 4–5 (days 22–35) | Week 10 (days 64–70) | Week 17 (days 113–119) | Week 38 (days 260–266) | Week 122 (days 848–854) |
|---|---|---|---|---|---|---|---|---|---|
PCV or haematocrit (RI) (%) | 1 | 8a (33–34)c | 22a (33–34)c | 30b (33–34)c | 29b (32–35)c | 34b (34–36)c | 40b (30–37)c | na | 37b (33–45) |
2 | 18a (33–34)c | 23a (33–34)c | 33b (33–34)c | 29b (32–35)c | 34b (34–36)c | 38b (30–37)c | na | 36b (33–45) | |
3 | 14a (33–34)c | 19a (33–34)c | 25a (33–34)c | 28b (32–35)c | 29b (34–36)c | 36b (30–37)c | na | 32b (33–45) | |
4 | 8a (27–47) | 9b (27–47) | 20b (27–47) | 27b (27–47) | na | na | 13b (27–47) | na | |
5 | 35b (27-47) | na | na | 41b (27–47) | na | na | na | na | |
MCV (RI) (fl) | 1 | 71 (47–49)c | na | 41 (47–49)c | na | 34 (42–45)c | na | na | 37 (41–49) |
2 | na | na | 51 (47–49)c | na | 38 (42–45)c | na | na | 40 (41–49) | |
3 | na | na | 47 (47–49)c | na | 36 (42–45)c | na | na | 41 (41–49) | |
4 | na | 36 (37–55) | 61 (37–55) | 47 (37–55) | na | na | 54 (37–55) | na | |
5 | na | na | na | 41 (37–55) | na | na | na | na | |
MCHC (RI) (g/l) | 1 | 330 (291–299)c | na | 350 (291–299)c | na | 360 (308–324)c | na | na | 350 (330–360) |
2 | na | na | 320 (291–299)c | na | 350 (308–324)c | na | na | 350 (330–360) | |
3 | na | na | 290 (291–299)c | na | 360 (308–324)c | na | na | 360 (330–360) | |
4 | na | 392 (263–359) | 317 (263–359) | 336 (263–359) | na | na | 351 (263–359) | na | |
5 | na | na | na | 324 (263–359) | na | na | na | na | |
Reticulocytes (RI) (×109/l) | 1 | 250 (≤ 60)c | na | na | na | na | na | na | na |
2 | 570 (≤ 60)c | na | na | na | na | na | na | na | |
3 | 470 (≤ 60)c | na | na | na | na | na | na | na | |
4 | na | 13 (4–94) | 185 (4–94) | 19 (4–94) | na | na | 163 (4–94) | na | |
5 | na | na | na | 20 (4–94) | na | na | na | na | |
Leucocytes (RI) (×109/l) | 1 | 32 (22–26)c | na | 12 (22–26)c | na | 10 (19–21)c | na | na | 9 (5–13) |
2 | na | na | 14 (22–26)c | na | 10 (19–21)c | na | na | 8 (5–13) | |
3 | na | na | 12 (22–26)c | na | 8 (19–21)c | na | na | 8 (5–13) | |
4 | na | 7 (7–15) | 10 (7–15) | 11 (7–15) | na | na | 8 (7–15) | na | |
5 | na | na | na | 10 (7–15) | na | na | na | na | |
Platelets (RI) (×109/l) | 4 | na | 86 (180–430) | clumps | 407 (180–430) | na | na | clumps | na |
5 | na | na | na | clumps | na | na | na | na |